Platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine, AGEPC) and sodium vanadate (a phosphotyrosine phosphatase inhibitor) induced a time-and concentration-dependent increase in phosphotyrosine in several proteins and stimulated prostaglandin (PG) E2 production in cultured rat Kupffer cells. In addition, vanadate induced a decrease in the surface expression of AGEPC receptors and, as a consequence, inhibited AGEPC-stimulated PGE2 production. The vanadate-induced decrease in the surface expression of AGEPC receptors was time-and concentration-dependent and was partially prevented by genistein, a putative tyrosine kinase inhibitor. Upon removal of vanadate from the culture medium and re-incubation of cells in vanadate-free medium, the surface AGEPC receptors were restored within 7 h after the removal of vanadate. Both AGEPC-and vanadate-stimulated PGE2 formation was attenuated by genistein. Thus the present investigation demonstrates that both AGEPC and sodium vanadate stimulate tyrosine phosphorylation of cellular proteins, and vanadate induces a decrease in the number of the surface AGEPC receptors. These results suggest that protein tyrosine phosphorylation may play a role, directly or indirectly, in the regulation of surface expression of AGEPC receptors as well as in PGE2 production in response to vanadate and AGEPC.
INTRODUCTION
Platelet-activating factor ('PAF') is a unique phosphoglyceride which possesses a variety of biological functions in different tissues and cells (see [1] [2] [3] [4] for reviews). The chemical structure of this lipid mediator was found to be l-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine and is referred to as AGEPC in the present study [5] [6] [7] . AGEPC elicits most of its biological effects via specific receptors, which usually are located on the surface of cells and are widely distributed in various tissues and cells [8] . In platelets [9-1 1] , neutrophils [12] and glomerular mesangial cells [13] , signal transduction from specific AGEPC receptors to various effector systems involves GTP-binding protein(s). AGEPC stimulates the hydrolysis of polyphosphoinositides, which generates two second messengers, inositol 1,4,5-trisphosphate and diacylglycerol [14] [15] [16] [17] . Also, AGEPC stimulates the activity of phospholipase A2, leading to the release of arachidonic acid from cellular phospholipids through Gprotein- [12] and Ca21- [18, 19] dependent mechanisms.
Tyrosine kinase activity is associated with receptor-mediated signal transduction of insulin receptors [20] , as well as other growth-factor receptors [21, 22] . Recent reports have suggested that a tyrosine kinase may be involved in AGEPC-stimulated phosphoinositide metabolism in platelets [23] and arachidonic acid metabolism in the macrophage cell line P388D1 [24] . The tyrosine kinase inhibitor genistein [25] inhibits significantly the stimulatory effect of AGEPC in these two processes [23, 24] , and AGEPC promotes protein tyrosine phosphorylation in platelets [23] , neutrophils [26] and rat liver macrophages [27] .
Vanadate is a phosphate analogue which affects enzymic activities involving phosphate-transfer processes such as protein phosphorylation/dephosphorylation reactions [28] and reactions utilizing ATP [29] . Vanadate has been shown to inhibit phosphotyrosine phosphatase activity [30] and to stimulate tyrosine kinase [31, 32] , leading to an accumulation of phosphotyrosine in various cellular proteins. Vanadate is believed to modulate receptors for insulin and insulin-like growth factor by stimulating the phosphorylation of tyrosine residues of the respective receptors [33, 34] . In addition, vanadate has been shown to stimulate DNA synthesis [35] and inhibit Na+/K+-ATPase [29] .
In the present study, the effect of AGEPC and vanadate on tyrosine phosphorylation in Kupffer cells was investigated, and the possible role of the protein tyrosine phosphorylation on AGEPC-receptor function was explored. It was found that both AGEPC and vanadate induced a time-and concentrationdependent increase in tyrosine phosphorylation of several cellular proteins. Also, evidence is presented indicating that the tyrosine phosphorylation of cellular protein(s) is likely to be involved in the vanadate-induced alteration of surface expression of AGEPC receptors and in AGEPC-receptor-mediated eicosanoid production. A preliminary report of this study has been published [36] .
EXPERIMENTAL
Isolation and primary culture of rat Kupffer cells Rat Kupffer cell suspensions were prepared by centrifugal elutriation [37] and cultured as described previously [38] .
13HIAGEPC binding to cultured rat Kupffer cells
The ligand-binding experiments were performed essentially as Abbreviations used: AGEPC, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine; lysoGEPC, 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine; PG, prostaglandin; PMA, phorbol 12-myristate 13- Vol. 288 777 described previously [19, 38] . Specific AGEPC binding is defined as the difference between total binding (measured in the absence of 1.0 /M unlabelled AGEPC) and non-specific binding (measured in the presence of 1.0 /M unlabelled AGEPC). Scatchard analysis was performed by a computer-fitting program.
Radioimmunoassay of prostaglandin (PG) E2
Kupffer cells cultured in regular RPMI 1640 medium were rinsed three times with serum-free Hanks' buffer. The same buffer was added to each plate and the incubation was continued for 15 min, after which the cells were challenged with 10 nM-AGEPC or other compounds for the desired time period. In certain experiments, cells were pretreated with vanadate or genistein in the regular culture medium before stimulation. The amount of PGE2 released into the incubation medium by cultured Kupffer cells was assayed by a radioimmunoassay as described previously [39] .
Western blots of phosphotyrosine Tyrosine phosphorylation was assayed as follows. Cells cultured in RPMI 1640 medium (4 x 106 cells/35 mm plate) were stimulated with vanadate or AGEPC for different time periods. The reaction was terminated by aspiration of the medium and immediate addition of 50 ,1 of immunoprecipitation buffer containing 50 mM-Tris/HCl, pH 7.4, 150 mM-NaCl, 0.5 mMsodium orthovanadate, 5 mM-EDTA, 1 % Triton X-100, 0.1 % SDS, 1 % deoxycholic acid, 20 ,ug of leupeptin/ml, 20 jtg phenylmethanesulphonyl fluoride/ml, 100 units of aprotinin/ml and 10 mg of p-nitrophenyl phosphate/ml. The precipitation buffer was transferred to an Eppendorf vial containing 50 ,1 of 2 x concentrated SDS sample buffer, which contained 0.125 MTris/HCl, pH 6.8, 4% SDS, 20% glycerol and 100% mercaptoethanol. The mixture was heated at 95°C for 5 min before being subjected to SDS/PAGE. Samples (90,l) (e.g. containing approx. 50,ug of protein) were applied to 10%-polyacrylamide slab gels and were electrophoresed at constant current (30 mA per gel) as described by Laemmli [40] . Purified protein markers were electrophoresed simultaneously in this system to estimate the molecular masses of the cellular proteins. Proteins on the gel were transferred to a Millipore Immobilon-P transfer membrane (a polyvinylidene difluoride membrane) in cold (4°C) transfer buffer containing 25 mM-Tris/HCl, pH 8.3, 0.075 % SDS, 0.2 M-glycine, 20 % methanol and 0.5 mM-sodium vanadate by using a constant current of 200 mA for 4-5 h. The membrane was blocked overnight at 4°C in a blocking solution [10 mM-Tris/HCl, pH 7.2, 150 mM-NaCl and 3 % BSA (Sigma, fraction V)] and incubated with monospecific anti-phosphotyrosine antibodies (1 ,ug/ml) in blocking solution at 25°C for 2-4 h. The membrane was washed extensively (5 times, 5 min/ wash) with rinsing buffer (10 mM-Tris/HCl, pH 7.2, 150 mMNaCl, 0.05 % Tween 20 and 0.05 % Nonidet P-40) and immunoblotted by using 251I-Protein A (2-4 h, room temperature). The membrane was washed as described above, dried, and autoradiographed at -80°C using Kodak X-Omat AR film. Some of the autoradiograms were quantified by measuring the integrated density by using a computer imaging system.
Determination of protein
Protein was quantified with the bicinchoninic acid protein assay essentially as described by Smith et al. [41] . The Figs. 1 and 2 , at least five cellular proteins were phosphorylated on tyrosine residues in this cellular system. The predominant phosphorylated protein (pp8O) exhibited an approximate molecular mass of 80 kDa. The stimulatory effect of AGEPC (10 nM) was time-dependent (5 s-5 min) with maximal stimulation seen within 2 min [27] and was concentration-dependent (Fig. 1) . When the phosphorylation of pp8O was quantified, an EC50 value of 0.8 nm was obtained (Fig. 1) . LysoGEPC, an inactive metabolite and immediate precursor ofAGEPC, at concentrations as high as 100 nm had no effect on tyrosine phosphorylation in this system ( WEB 2170 inhibited completely the protein tyrosine phosphorylation stimulated by AGEPC, whereas WEB 2086 showed a partial inhibitory effect (Fig. 2) . AGEPC-promoted tyrosine phosphorylation was inhibited by genistein, a specific tyrosine kinase inhibitor [25, 42] , in the concentration range 25-100 /tM (Fig. 3) . Furthermore, the detection of the phosphotyrosine in the cellular proteins was inhibited competitively by 2 mMphosphotyrosine, but not by the same concentration of phosphoserine or phosphothreonine during immunoblotting, suggesting the tyrosine-specificity of the immunoblotting assay (results not shown).
Vanadate-stimulated protein tyrosine phosphorylation. The vanadate-promoted protein tyrosine phosphorylation was examined by two different protocols: (a) high concentrations (mM) for a short period (minutes) (Fig. 4a ) and (b) low concentrations (,uM) for a long term (hours) (Fig. 4b) . In Fig. 4 (Fig. 4b) . The tyrosine phosphorylation induced by vanadate was strongly inhibited by pretreatment of cells with genistein (Fig. 4c) Fig. 6a ). Scatchard analysis revealed that the Bmax decreased from 95 fmol to 28 fmol, but the slope of the Scatchard plot did not change appreciably (Kd = 0.41 nm in the control versus 0.51 nm in the vanadate-treated) when cells were pretreated with 10 mM-vanadate (Fig. 6b) [15] [16] [17] [18] [19] [20] min, followed by stimulation with various concentrations of AGEPC. At the end of the incubation period, the Hanks' buffer was removed and immediately frozen for subsequent prostaglandin measurement. As illustrated in Fig. 9 , vanadate at relatively low concentrations (i.e. between 10,uM and 0.5 mM), did not inhibit the effect of AGEPC, but rather enhanced slightly the subsequent AGEPCstimulated PGE2 production as observed in rat liver cell line C-9. As shown in Fig. 5 , vanadate in this concentration range (60 min incubation) did not appreciably alter specific AGEPC binding. However, at higher concentrations (i.e. 0.5-10 mM) vanadate caused a concentration-dependent inhibition of AGEPC-stimulated PGE2 production, with an EC50 value of approx. 1.8 mm (Fig. 9 ). This value was close to the EC50 value (2.0 mM) for the inhibitory effect ofvanadate on AGEPC receptor binding (Fig. 5) .
Effect of genistein on AGEPC-and vanadate-stimulated PGE2 production. Since vanadate inhibits phosphotyrosine phosphatase and possibly stimulates tyrosine kinase [30] [31] [32] , it was decided to ascertain whether vanadate stimulates PGE2 production, and whether such an effect of vanadate might be inhibited by genistein in cultured Kupffer cells. Similar to experiments examining tyrosine phosphorylation and ligand binding, PGE2 production was measured in two experimental protocols: a short term with high concentrations of vanadate and a long period of time with low concentrations of vanadate. Cells were washed with serumfree Hanks' buffer and incubated in the same buffer at 37°C for a brief period of time (20 min), followed by incubation with various compounds for another 15 min. As shown in- Fig. 10(a) , vanadate at concentrations in the range 0.1-10 mm stimulated PGE2 production, and this effect was inhibited significantly by pretreatnent of the cells with genistein (30 AM). When-cells were incubated in RPMI 1640 medium (with or without 10% fetalbovine serum) in the absence or presence of various concentrations of vanadate (5-30 /sM) for 24 h, it was found that a large amount of PGE2 accumulated in medium from the control cells (9.54 + 1.46 ng/ml; n = 3) and that the presence of vanadate (5 uM) did not increase significantly PGE2 synthesis (10.33 +1.51 ng/ml; n = 3). No PGE2 was detected in the medium which had not been incubated with Kupffer cells. In addition, as expected, AGEPC (10 nM) stimulated PGE2 production in Kupffer cells. Genistein (30 /uM) significantly decreased the stimulatory effect of AGEPC by nearly 80 % (Fig. lOb) .
DISCUSSION
Tyrosine-specific protein kinases are involved in the signaltransduction mechanisms of a number of growth factors, e.g. epidermal growth factor [21;,22] a"nd platelet-derived growth factor 142,43], and of insulin [20] . Receptors for the growth factors and insulin possess single-pass transmembrane segments and have intrinsic tyrosine kinase catalytic activity. These features distinguish this family of receptors from other receptor families, which for instance have seven transmembrane domains, are linked to various response elements-via GTP-binding protein(s), and have no apparent catalytic activity, e.g. catecholamine receptors [44] . Similar to the catecholamine receptor, a recent study demonstrated that AGEPC receptor molecule has seven transmembrane segments and belongs to the superfamily of receptors which interact with GTP-binding proteins [45] .
Recent studies have indicated that tyrosine kinase activation is involved in signal transduction stimulation by AGEPC in platelets (phosphoinositide turnover) [23] and in macrophages (arachidonic acid metabolism) [24] . AGEPC was found to stimulate protein tyrosine phosphorylation in rabbit platelets [23] and in human neutrophils [26] . Although the identity of the tyrosine-phosphorylated proteins which were increased in response to AGEPC is unknown, it has been proposed that tyrosine phosphorylation may regulate the activities of both phospholipase C and phospholipase A2. (Figs. 4a and 4b) . Genistein (30 uM), a specific tyrosine kinase inhibitor, inhibited the stimulatory effect of vanadate (Fig. 4c) . Vanadate has been found not only to inhibit phosphotyrosine phosphatase, thereby increasing the accumulation of phosphotyrosine [30] , but to stimulate the activity of tyrosine kinase as well [31, 32] . Of particular significance is the fact that vanadate causes protein tyrosine phosphorylation of insulin receptors, leading to the down-regulation of the insulin receptor [33] .
An important finding in the present study was (Fig. 7) . The decrease in specific AGEPC binding was due primarily to a loss of specific AGEPC binding sites rather than to an alteration of the binding affinity for AGEPC, as assessed by Scatchard analysis of the binding data (Fig. 6) . Compared with the time course of the effect of vanadate on the insulin receptor (e.g, the inhibition is not seen until 6 h after addition of vanadate) [34, 47] , the vanadate-induced down-regulation -of AGEPC receptors was rapid, with the half-maximal effect seen within 10-20 min. Similarly to the present study, vanadate (10 mM) induced a rapid decrease in the surface asialo-orosomucoid receptor in rat liver parenchymal cells, reaching a half-maximal effect within 2.5-5 min [48] . Pretreatment with vanadate followed by an extensive washing also attenuated the AGEPC-stimulated cellular responses, i.e. PGE2 formation. The EC50 values for the inhibitory effect of vanadate on PGE2 production and the regulation of the AGEPC receptor were comparable, suggesting that the vanadate-induced inhibition of PGE2 production stimulated by AGEPC was a consequence of a loss of surface AGEPC receptors.
The molecular mechanism for the vanadate-induced loss of surface AGEPC receptors is not known. Numerous (Table 1) suggested that these two events may be related. However, it should be pointed out that, although we believe that vanadate induces AGEPC-receptor down-regulation through a mechanism(s) involving tyrosine phosphorylation, either directly or indirectly, the possibility remains that vanadate alters AGEPC-receptor metabolism through effects independent of phosphorylation reactions.
Vanadate at concentrations between 0.1 and 10 mm for a brief period of time (30 min) stimulated PGE2 production in the cultured Kupffer cell. Similar to the AGEPC-stimulated PGE2 production, the vanadate-elicited response was attenuated in cells pretreated with genistein. This result supports the hypothesis that both AGEPC-and vanadate-stimulated PGE2 production may involve activation of tyrosine-specific protein kinase(s). Supporting this hypothesis was the observation that vanadate, at a concentration of 11 tM, amplified the eicosanoid production of rat liver cells (C-9 cell line) stimulated with AGEPC [52] . It should be noted that this stimulatory effect of vanadate observed in the present study differs from its inhibitory effect on AGEPCstimulated PGE2 production, which may be due to the decreased expression of AGEPC receptor during the vanadate preincubation. The regulatory effect of tyrosine kinase on AGEPC-stimulated phosphoinositide turnover in platelets [23] and on lipopolysaccharide-primed AGEPC-stimulated arachidonic acid metabolism in macrophage P388D1 cells [24] has been observed. In addition to tyrosine kinase, other protein kinases such as protein kinase C also may play a role in AGEPCstimulated arachidonic acid metabolism [53, 54] . Recent studies in our laboratory have indicated that AGEPC-stimulated PGE2 production in cultured Kupffer cells was inhibited significantly by two protein kinase C inhibitors, staurosporine (which interacts with the catalytic domain of protein kinase C) and calphostin C (which interacts with the regulatory domain of protein kinase C), and in the cells down-regulated for protein kinase C [27] . These results suggest that AGEPC-stimulated arachidonic acid metabolism in various cell-types can be regulated by several protein kinases, including tyrosine kinase and protein kinase C [27, 39, 53, 54] 
